Stay updated on Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Only minor, non-core updates to the study record are present; core details such as eligibility criteria, primary/secondary outcomes, and overall status remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:20:59.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Adds a government-operations notice and a v3.2.0 revision; removes the Small cell lung carcinoma resource and updates the version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T06:00:15.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:12:07.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 (replacing v3.0.1); the Back to Top element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:55:39.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T16:54:51.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to small cell lung carcinoma and various types of antibodies and proteins. Notably, the previous version's references to certain cancer-related topics and specific agents have been removed.
    Difference
    4%
    Check dated 2025-08-31T12:14:45.000Z thumbnail image

Stay in the know with updates to Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.